Table 4 Characteristics of METABRIC TNBC patients.

From: CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer

Characteristic

TNBC patients (n = 199)

CD8 T cells (0.25 * sd)

T cells gamma delta (0.25 * sd)

High CD8 T cells (n = 65)

Low CD8 T cells (n = 101)

p

High T cells gamma delta (n = 66)

Low T cells gamma delta (n = 103)

p

Mean age at pathologic diagnosis

53.9

53.6

54.7

0.77*

53.0

54.2

0.75*

Tumor stage

   

0.96#

  

0.93#

I–II

129 (65%)

42 (65%)

67 (66%)

Y

44 (67%)

65 (63%)

Y

III–IV

12 (6%)

4 (6%)

7 (7%)

Y

4 (6%)

6 (6%)

Y

NA

58 (29%)

19 (29%)

27 (27%)

Y

18 (27%)

32 (31%)

Y

Inferred menopause

   

0.87#

  

0.97#

Pre

82 (41%)

28 (43%)

42 (42%)

Y

27 (41%)

43 (42%)

Y

Post

117 (59%)

37 (57%)

59 (58%)

Y

39 (59%)

60 (58%)

Y

  1. METABRIC: Molecular Taxonomy of Breast Cancer International Consortium; TNBC: triple negative breast cancer; p: pvalue; sd: standard deviation; *: Wilcoxon test; #: Fisher’s exact test; Y: Used in Fisher’s exact test; N: Not used for Fisher’s exact test; NA: missing data.
Back to article page